Medtronic (MDT) Equity Ratio (2014 - 2026)

Medtronic has disclosed Equity Ratio across 13 years of filings, most recently posting 0.54 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.54, down 2.48% year-over-year; the trailing twelve-month figure through Jan 2026 was 0.54 (down 2.48% YoY), and the FY2025 annual result was 0.53, down 6.07% from the prior year.
• Equity Ratio came in at 0.54 for Q1 2026 at Medtronic, up from 0.53 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.59 in Q3 2022 to a low of 0.53 in Q2 2025.
• The 5-year median for Equity Ratio is 0.56 (2022), against an average of 0.56.
• Across the five-year window, Equity Ratio climbed 9.67% in 2022 and slipped 6.07% in 2025, its largest moves.
• Medtronic's Equity Ratio stood at 0.56 in 2022, then gained by 2.69% to 0.57 in 2023, then slipped by 5.63% to 0.54 in 2024, then slipped by 1.14% to 0.53 in 2025, then gained by 0.54% to 0.54 in 2026.
• The last three Equity Ratio figures came in at 0.54 (Q1 2026), 0.53 (Q4 2025), and 0.53 (Q3 2025), per Business Quant data.